Intravenous Artesunate for Severe Malaria in Travelers, Europe

Intravenous Artesunate for Severe Malaria in Travelers, Europe

Multicenter trials in Southeast Asia have shown better survival rates among patients with severe malaria, particularly those with high parasitemia levels, treated with intravenous (IV) artesunate than among those treated with quinine. In Europe, quinine is still the primary treatment for severe mala...

Full description

Bibliographic Details
Main Authors: Thomas Zoller, Thomas Junghanss, Annette Kapaun, Ida Gjørup, Joachim Richter, Mats Hugo-Persson, Kristine Mørch, Behruz Foroutan, Norbert Suttorp, Salih Yürek, Holger Flick
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2011-05-01
Series:Emerging Infectious Diseases
Subjects:
artesunate
Plasmodium falciparum
parasites
malaria
hemolysis
critical care
Online Access:https://wwwnc.cdc.gov/eid/article/17/5/10-1229_article

Internet

https://wwwnc.cdc.gov/eid/article/17/5/10-1229_article

Similar Items